Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

AstraZeneca Total Assets 2010-2025 | AZN

AstraZeneca total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • AstraZeneca total assets for the quarter ending March 31, 2025 were $106.253B, a 3.87% increase year-over-year.
  • AstraZeneca total assets for 2024 were $104.035B, a 2.88% increase from 2023.
  • AstraZeneca total assets for 2023 were $101.119B, a 4.8% increase from 2022.
  • AstraZeneca total assets for 2022 were $96.483B, a 8.43% decline from 2021.
  
AstraZeneca Annual Total Assets
(Millions of US $)
2024 $104,035
2023 $101,119
2022 $96,483
2021 $105,363
2020 $66,729
2019 $61,377
2018 $60,651
2017 $63,354
2016 $62,526
2015 $60,056
2014 $58,595
2013 $55,899
2012 $53,534
2011 $52,830
2010 $56,127
2009 $54,920
AstraZeneca Quarterly Total Assets
(Millions of US $)
2025-03-31 $106,253
2024-12-31 $104,035
2024-09-30 $104,922
2024-06-30 $104,340
2024-03-31 $102,293
2023-12-31 $101,119
2023-09-30 $96,086
2023-06-30 $96,543
2023-03-31 $96,687
2022-12-31 $96,483
2022-09-30 $94,185
2022-06-30 $96,579
2022-03-31 $100,273
2021-12-31 $105,363
2021-09-30 $107,221
2021-06-30 $73,641
2021-03-31 $64,926
2020-12-31 $66,729
2020-09-30 $64,112
2020-06-30 $59,929
2020-03-31 $57,211
2019-12-31 $61,377
2019-09-30 $58,906
2019-06-30 $61,889
2019-03-31 $61,055
2018-12-31 $60,651
2018-09-30 $61,443
2018-06-30 $61,344
2018-03-31 $63,281
2017-12-31 $63,354
2017-09-30 $64,587
2017-06-30 $65,119
2017-03-31 $60,959
2016-12-31 $62,526
2016-09-30 $63,222
2016-06-30 $64,419
2016-03-31 $64,323
2015-12-31 $60,056
2015-09-30 $54,118
2015-06-30 $55,169
2015-03-31 $53,701
2014-12-31 $58,595
2014-09-30 $56,164
2014-06-30 $58,539
2014-03-31 $59,390
2013-12-31 $55,899
2013-09-30 $54,121
2013-06-30 $53,987
2013-03-31 $52,329
2012-12-31 $53,534
2012-09-30 $52,448
2012-06-30 $51,390
2012-03-31 $50,763
2011-12-31 $52,830
2011-09-30 $52,576
2011-06-30 $53,406
2011-03-31 $54,534
2010-12-31 $56,127
2010-09-30 $56,390
2010-06-30 $54,647
2010-03-31 $54,075
2009-12-31 $54,920
2009-09-30 $51,899
2009-06-30 $50,200
2009-03-31 $46,515
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $219.635B $54.073B
AstraZeneca plc, is one of the largest biopharmaceutical companies in the world. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases and other.In July 2021 AstraZeneca closed the acquisition of rare disease drugmaker, Alexion. The acquisition added Alexion's five marketed rare disease products and its pipeline of immune-mediated rare disease candidates.In order to bolster its respiratory portfolio, AstraZeneca acquired rights to Allergan's branded respiratory business in the U.S. and Canada in Mar 2015. The company also acquired Takeda's core respiratory business in May 2016.In June 2007, AstraZeneca acquired biotechnology company MedImmune. In Aug 2011, AstraZeneca sold its Astra Tech business to DENTSPLY. AstraZeneca entered into a number of deals and struck agreements with companies such as FibroGen and Daiichi Sankyo.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $159.441B 14.28
Gilead Sciences (GILD) United States $140.863B 14.63
Vertex Pharmaceuticals (VRTX) United States $122.997B 0.00
Bristol Myers Squibb (BMY) United States $96.992B 6.49
GSK (GSK) United Kingdom $79.928B 9.57
CSL (CSLLY) Australia $77.619B 0.00
Regeneron Pharmaceuticals (REGN) United States $59.660B 14.48
Alnylam Pharmaceuticals (ALNY) United States $41.838B 0.00
Argenex SE (ARGX) Netherlands $33.900B 92.53
BioNTech SE (BNTX) Germany $26.871B 0.00
Royalty Pharma (RPRX) United States $20.168B 8.52
Biogen (BIIB) United States $19.491B 8.41
Insmed (INSM) United States $18.302B 0.00
Illumina (ILMN) United States $15.425B 29.26
Genmab (GNMSF) Denmark $14.206B 14.53
Genmab (GMAB) Denmark $13.844B 15.52
Incyte (INCY) United States $13.302B 101.06
Moderna (MRNA) United States $12.681B 0.00
Exelixis (EXEL) United States $12.018B 20.40
BioMarin Pharmaceutical (BMRN) United States $11.443B 18.59
Ascendis Pharma (ASND) Denmark $10.742B 0.00
QIAGEN (QGEN) Netherlands $10.661B 20.74
Exact Sciences (EXAS) United States $10.434B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.413B 26.59
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.919B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $8.604B 0.00
Blueprint Medicines (BPMC) United States $8.302B 0.00
Bio-Techne Corp (TECH) United States $8.244B 30.75
Roivant Sciences (ROIV) United Kingdom $7.627B 0.00
Anbio Biotechnology (NNNN) Germany $7.455B 0.00
Repligen (RGEN) United States $7.294B 81.65
Legend Biotech (LEGN) United States $7.250B 0.00
Revolution Medicines (RVMD) United States $7.175B 0.00
Halozyme Therapeutics (HALO) United States $6.972B 13.34
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Jazz Pharmaceuticals (JAZZ) Ireland $6.753B 6.63
Guardant Health (GH) United States $6.323B 0.00
TG Therapeutics (TGTX) United States $6.020B 158.00
Nuvalent (NUVL) United States $5.852B 0.00
Telix Pharmaceuticals (TLX) Australia $5.725B 0.00
Rhythm Pharmaceuticals (RYTM) United States $5.662B 0.00
Axsome Therapeutics (AXSM) United States $5.532B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.189B 0.00
Alkermes (ALKS) Ireland $4.944B 13.27
Vaxcyte (PCVX) United States $4.616B 0.00
ADMA Biologics Inc (ADMA) United States $4.378B 32.75
Cytokinetics (CYTK) United States $4.374B 0.00
Krystal Biotech (KRYS) United States $4.303B 33.16
Zealand Pharma (ZLDPF) Denmark $4.230B 0.00
Akero Therapeutics (AKRO) United States $4.076B 0.00
Zai Lab (ZLAB) China $3.961B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.918B 0.00
PTC Therapeutics (PTCT) United States $3.863B 6.72
Arcellx (ACLX) United States $3.802B 0.00
Merus (MRUS) Netherlands $3.773B 0.00
Avidity Biosciences (RNA) United States $3.769B 0.00
Metsera (MTSR) United States $3.711B 0.00
Scholar Rock Holding (SRRK) United States $3.512B 0.00
Viking Therapeutics (VKTX) United States $3.414B 0.00
Protagonist Therapeutics (PTGX) United States $3.241B 69.72
MoonLake Immunotherapeutics (MLTX) Switzerland $3.091B 0.00
Immunovant (IMVT) United States $2.955B 0.00
Kymera Therapeutics (KYMR) United States $2.942B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.841B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.648B 0.00
Alvotech (ALVO) Luxembourg $2.635B 15.07
Arrowhead Pharmaceuticals (ARWR) United States $2.607B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.508B 0.00
ImmunityBio (IBRX) United States $2.463B 0.00
Apellis Pharmaceuticals (APLS) United States $2.414B 0.00
Ligand Pharmaceuticals (LGND) United States $2.362B 0.00
Twist Bioscience (TWST) United States $2.344B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.272B 0.00
Agios Pharmaceuticals (AGIO) United States $2.263B 0.00
Denali Therapeutics (DNLI) United States $2.179B 0.00
Beam Therapeutics (BEAM) United States $2.158B 0.00
Bavarian Nordic (BVNRY) Denmark $2.157B 11.40
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.102B 0.00
Vericel (VCEL) United States $2.089B 1383.33
CG Oncology (CGON) United States $2.061B 0.00
Belite Bio (BLTE) United States $2.043B 0.00
NovoCure (NVCR) Jersey $2.028B 0.00
IDEAYA Biosciences (IDYA) United States $2.012B 0.00
Amicus Therapeutics (FOLD) United States $1.977B 214.00
Harmony Biosciences Holdings (HRMY) United States $1.969B 13.09
Disc Medicine (IRON) United States $1.935B 0.00
Sarepta Therapeutics (SRPT) United States $1.904B 0.00
Certara (CERT) United States $1.861B 34.76
Adaptive Biotechnologies (ADPT) United States $1.812B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.737B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.735B 0.00
Apogee Therapeutics (APGE) United States $1.705B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.695B 0.00
Vera Therapeutics (VERA) United States $1.544B 0.00
89BIO (ETNB) United States $1.542B 0.00
GRAIL (GRAL) United States $1.516B 0.00
Janux Therapeutics (JANX) United States $1.508B 0.00
Celldex Therapeutics (CLDX) United States $1.491B 0.00
Edgewise Therapeutics (EWTX) United States $1.482B 0.00
Biohaven (BHVN) United States $1.479B 0.00
Travere Therapeutics (TVTX) United States $1.450B 0.00
ANI Pharmaceuticals (ANIP) United States $1.415B 14.58
Viridian Therapeutics (VRDN) United States $1.390B 0.00
Mesoblast (MESO) Australia $1.343B 0.00
Dynavax Technologies (DVAX) United States $1.298B 77.21
Intellia Therapeutics (NTLA) United States $1.256B 0.00
CureVac (CVAC) Germany $1.234B 5.98
WAVE Life Sciences (WVE) Singapore $1.198B 0.00
Cogent Biosciences (COGT) United States $1.184B 0.00
MannKind (MNKD) United States $1.161B 23.88
Liquidia Technologies (LQDA) United States $1.152B 0.00
Novavax (NVAX) United States $1.140B 2.66
Structure Therapeutics (GPCR) United States $1.095B 0.00
Pacira BioSciences (PCRX) United States $1.073B 10.21
MiMedx (MDXG) United States $1.028B 24.86
Cidara Therapeutics (CDTX) United States $1.028B 0.00
Praxis Precision Medicines (PRAX) United States $1.023B 0.00
Nurix Therapeutics (NRIX) United States $1.005B 0.00
Spyre Therapeutics (SYRE) United States $0.998B 0.00
Arcus Biosciences (RCUS) United States $0.988B 0.00
LENZ Therapeutics (LENZ) United States $0.980B 0.00
NeoGenomics (NEO) United States $0.969B 0.00
Pharvaris (PHVS) Netherlands $0.967B 0.00
BGM Group (BGM) China $0.958B 0.00
Niagen Bioscience (NAGE) United States $0.955B 134.67
Zymeworks (ZYME) United States $0.946B 0.00
Mineralys Therapeutics (MLYS) United States $0.937B 0.00
Oric Pharmaceuticals (ORIC) United States $0.929B 0.00
Sionna Therapeutics (SION) United States $0.924B 0.00
Anavex Life Sciences (AVXL) United States $0.919B 0.00
Geron (GERN) United States $0.917B 0.00
Sana Biotechnology (SANA) United States $0.913B 0.00
Vir Biotechnology (VIR) United States $0.820B 0.00
UniQure (QURE) Netherlands $0.815B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
Nuvation Bio (NUVB) United States $0.806B 0.00
GH Research (GHRS) Ireland $0.805B 0.00
Oculis Holding AG (OCS) Switzerland $0.805B 0.00
Replimune (REPL) United States $0.801B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.795B 0.00
Immunome (IMNM) United States $0.774B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
CorMedix Inc (CRMD) United States $0.770B 51.59
AnaptysBio (ANAB) United States $0.756B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.754B 0.00
Gyre Therapeutics (GYRE) United States $0.750B 200.00
ArriVent BioPharma (AVBP) United States $0.730B 0.00
Trevi Therapeutics (TRVI) United States $0.724B 0.00
Immatics (IMTX) Germany $0.717B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.710B 0.00
Jyong Biotech (MENS) Taiwan $0.703B 0.00
Pharming Group (PHAR) Netherlands $0.681B 0.00
Dianthus Therapeutics (DNTH) United States $0.678B 0.00
MeiraGTx Holdings (MGTX) United States $0.673B 0.00
Iovance Biotherapeutics (IOVA) United States $0.665B 0.00
Maze Therapeutics (MAZE) United States $0.660B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.657B 0.00
Stoke Therapeutics (STOK) United States $0.656B 15.22
Tango Therapeutics (TNGX) United States $0.655B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.654B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.648B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Urogen Pharma (URGN) United States $0.637B 0.00
Upstream Bio (UPB) United States $0.629B 0.00
Prime Medicine (PRME) United States $0.611B 0.00
Arvinas (ARVN) United States $0.601B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.583B 0.00
Keros Therapeutics (KROS) United States $0.582B 0.00
Castle Biosciences (CSTL) United States $0.581B 39.45
Sage Therapeutics (SAGE) United States $0.576B 0.00
Precigen (PGEN) United States $0.561B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.554B 0.00
Tyra Biosciences (TYRA) United States $0.542B 0.00
Kura Oncology (KURA) United States $0.533B 0.00
Bicara Therapeutics (BCAX) United States $0.527B 0.00
Myriad Genetics (MYGN) United States $0.527B 0.00
Opthea (OPT) Australia $0.525B 0.00
Septerna (SEPN) United States $0.522B 0.00
Celcuity (CELC) United States $0.512B 0.00
Rapport Therapeutics (RAPP) United States $0.511B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.505B 0.00
ATyr Pharma (ATYR) United States $0.492B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.467B 0.00
Cullinan Therapeutics (CGEM) United States $0.460B 0.00
REGENXBIO (RGNX) United States $0.460B 0.00
Fortrea Holdings (FTRE) United States $0.456B 12.60
Cytek Biosciences (CTKB) United States $0.453B 0.00
Rezolute (RZLT) United States $0.452B 0.00
Kamada (KMDA) Israel $0.451B 27.07
MBX Biosciences (MBX) United States $0.444B 0.00
PureTech Health (PRTC) United States $0.440B 0.00
Zenas BioPharma (ZBIO) United States $0.439B 0.00
Erasca (ERAS) United States $0.436B 0.00
Solid Biosciences (SLDB) United States $0.428B 0.00
Terns Pharmaceuticals (TERN) United States $0.427B 0.00
Fulcrum Therapeutics (FULC) United States $0.427B 0.00
Eton Pharmaceuticals (ETON) United States $0.423B 0.00
Tectonic Therapeutic (TECX) United States $0.402B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.401B 0.00
Emergent Biosolutions (EBS) United States $0.398B 0.00
Humacyte (HUMA) United States $0.394B 0.00
ITeos Therapeutics (ITOS) United States $0.392B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.387B 0.00
Astria Therapeutics (ATXS) United States $0.382B 0.00
Vigil Neuroscience (VIGL) United States $0.382B 0.00
Compass Therapeutics (CMPX) United States $0.379B 0.00
Benitec Biopharma (BNTC) United States $0.363B 0.00
Amarin (AMRN) Ireland $0.359B 0.00
Cartesian Therapeutics (RNAC) United States $0.357B 0.00
Prothena (PRTA) Ireland $0.354B 0.00
Northwest Biotherapeutics (NWBO) United States $0.344B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.342B 0.00
Olema Pharmaceuticals (OLMA) United States $0.341B 0.00
XOMA Royalty (XOMA) United States $0.332B 0.00
Aura Biosciences (AURA) United States $0.331B 0.00
Ocugen (OCGN) United States $0.330B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.325B 66.12
Inventiva S.A (IVA) France $0.323B 0.00
Atea Pharmaceuticals (AVIR) United States $0.322B 0.00
Vor Biopharma (VOR) $0.317B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.312B 0.00
Citius Oncology (CTOR) United States $0.311B 0.00
Gossamer Bio (GOSS) United States $0.309B 0.00
Foghorn Therapeutics (FHTX) United States $0.307B 0.00
Candel Therapeutics (CADL) United States $0.305B 0.00
Annexon (ANNX) United States $0.304B 0.00
Neurogene (NGNE) United States $0.303B 0.00
Inhibrx Biosciences (INBX) United States $0.303B 0.18
Lifecore Biomedical (LFCR) United States $0.302B 0.00
DBV Technologies S.A (DBVT) France $0.301B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.296B 0.00
Sagimet Biosciences (SGMT) United States $0.291B 0.00
Crescent Biopharma (CBIO) United States $0.289B 0.00
Entrada Therapeutics (TRDA) United States $0.287B 9.35
Zhengye Biotechnology Holding (ZYBT) China $0.287B 0.00
Palvella Therapeutics (PVLA) United States $0.285B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.285B 0.00
Alpha Teknova (TKNO) United States $0.282B 0.00
Cardiff Oncology (CRDF) United States $0.271B 0.00
Allogene Therapeutics (ALLO) United States $0.265B 0.00
Verastem (VSTM) United States $0.264B 0.00
Editas Medicine (EDIT) United States $0.258B 0.00
Monopar Therapeutics (MNPR) United States $0.247B 0.00
Prima BioMed (IMMP) Australia $0.247B 0.00
Third Harmonic Bio (THRD) United States $0.246B 0.00
Adherex Technologies (FENC) United States $0.245B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.242B 0.00
Codexis (CDXS) United States $0.241B 0.00
MaxCyte (MXCT) United States $0.239B 0.00
Design Therapeutics (DSGN) United States $0.237B 0.00
Kodiak Sciences (KOD) United States $0.234B 0.00
Semper Paratus Acquisition (TVGN) United States $0.228B 0.00
Adocia (ADOCY) France $0.216B 0.00
ScPharmaceuticals (SCPH) United States $0.215B 0.00
CARGO Therapeutics (CRGX) United States $0.212B 0.00
AC Immune (ACIU) Switzerland $0.209B 0.00
Tvardi Therapeutics (TVRD) United States $0.207B 0.00
BioStem Technologies (BSEM) $0.205B 8.33
Eledon Pharmaceuticals (ELDN) United States $0.204B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.201B 0.00
CytomX Therapeutics (CTMX) United States $0.201B 5.19
Eupraxia Pharmaceuticals (EPRX) Canada $0.196B 0.00
EnGene Holdings (ENGN) Canada $0.196B 0.00
Voyager Therapeutics (VYGR) United States $0.192B 0.00
Alumis (ALMS) United States $0.190B 0.00
GENFIT S.A (GNFT) France $0.190B 0.00
SELLAS Life Sciences (SLS) United States $0.190B 0.00
I-Mab (IMAB) United States $0.189B 0.00
Bright Minds Biosciences (DRUG) United States $0.187B 0.00
Puma Biotechnology (PBYI) United States $0.179B 4.68
Tiziana Life Sciences (TLSA) United Kingdom $0.176B 0.00
Alpha Cognition (ACOG) Canada $0.173B 0.00
Ventyx Biosciences (VTYX) United States $0.171B 0.00
Spero Therapeutics (SPRO) United States $0.170B 0.00
Nuvectis Pharma (NVCT) United States $0.169B 0.00
Instil Bio (TIL) United States $0.168B 0.00
BioAge Labs (BIOA) United States $0.166B 0.00
DiaMedica Therapeutics (DMAC) United States $0.165B 0.00
Alector (ALEC) United States $0.165B 0.00
Neumora Therapeutics (NMRA) United States $0.165B 0.00
Caribou Biosciences (CRBU) United States $0.163B 0.00
Immuneering (IMRX) United States $0.160B 0.00
Anika Therapeutics (ANIK) United States $0.160B 0.00
Innate Pharma S.A (IPHA) France $0.159B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.155B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.152B 0.00
Black Diamond Therapeutics (BDTX) United States $0.150B 44.00
Compugen (CGEN) Israel $0.149B 0.00
Molecular Partners AG (MOLN) Switzerland $0.145B 0.00
Theratechnologies (THTX) Canada $0.144B 0.00
C4 Therapeutics (CCCC) United States $0.143B 0.00
Agenus (AGEN) United States $0.142B 0.00
Greenwich LifeSciences (GLSI) United States $0.141B 0.00
Rapt Therapeutics (RAPT) United States $0.140B 0.00
Kyverna Therapeutics (KYTX) United States $0.134B 0.00
Elicio Therapeutics (ELTX) United States $0.133B 0.00
Fate Therapeutics (FATE) United States $0.132B 0.00
Skye Bioscience (SKYE) United States $0.131B 0.00
Genelux (GNLX) United States $0.131B 0.00
Actuate Therapeutics (ACTU) United States $0.130B 0.00
23andMe Holding (MEHCQ) United States $0.129B 0.00
Nkarta (NKTX) United States $0.128B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.128B 0.00
Seer (SEER) United States $0.128B 0.00
Sangamo Therapeutics (SGMO) United States $0.123B 0.00
BioHarvest Sciences (BHST) Canada $0.120B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.114B 0.00
Oncolytics Biotech (ONCY) Canada $0.113B 0.00
Tenaya Therapeutics (TNYA) United States $0.109B 0.00
TuHURA Biosciences (HURA) United States $0.109B 0.00
Seres Therapeutics (MCRB) United States $0.108B 0.00
HilleVax (HLVX) United States $0.106B 0.00
TScan Therapeutics (TCRX) United States $0.104B 0.00
Coya Therapeutics (COYA) United States $0.104B 0.00
Contineum Therapeutics (CTNM) United States $0.104B 0.00
Nautilus Biotechnology (NAUT) United States $0.103B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
Elutia (ELUT) United States $0.101B 0.00
Coherus Oncology (CHRS) United States $0.101B 0.00
OKYO Pharma (OKYO) $0.099B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.099B 0.00
IO Biotech (IOBT) Denmark $0.095B 0.00
Whitehawk Therapeutics (WHWK) United States $0.095B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.094B 0.00
XBiotech (XBIT) United States $0.093B 0.00
BeyondSpring (BYSI) United States $0.093B 0.00
Zura Bio (ZURA) United States $0.092B 0.00
Climb Bio (CLYM) United States $0.091B 0.00
Cellectis S.A (CLLS) France $0.090B 0.00
Invivyd (IVVD) United States $0.090B 0.00
Adagene (ADAG) China $0.089B 0.00
Cabaletta Bio (CABA) United States $0.087B 0.00
EXoZymes (EXOZ) United States $0.085B 0.00
TELA Bio (TELA) United States $0.085B 0.00
Pliant Therapeutics (PLRX) United States $0.083B 0.00
Entera Bio (ENTX) Israel $0.083B 0.00
Forte Biosciences (FBRX) United States $0.082B 0.00
IGM Biosciences (IGMS) United States $0.081B 0.00
Quince Therapeutics (QNCX) United States $0.078B 0.00
Immunic (IMUX) United States $0.077B 0.00
Immix Biopharma (IMMX) United States $0.077B 0.00
Biomea Fusion (BMEA) United States $0.073B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.073B 0.00
VistaGen Therapeutics (VTGN) United States $0.073B 0.00
Genenta Science S.p.A (GNTA) Italy $0.072B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.071B 0.00
Alto Neuroscience (ANRO) United States $0.070B 0.00
Clearside Biomedical (CLSD) United States $0.068B 0.00
Repare Therapeutics (RPTX) Canada $0.068B 0.00
Sutro Biopharma (STRO) United States $0.066B 0.00
Opus Genetics (IRD) United States $0.066B 0.00
Oncobiologics (OTLK) United States $0.065B 0.00
Ikena Oncology (IKNA) United States $0.065B 0.00
MediciNova (MNOV) United States $0.062B 0.00
Senti Biosciences (SNTI) United States $0.061B 0.00
Connect Biopharma Holdings (CNTB) United States $0.060B 0.00
PDS Biotechnology (PDSB) United States $0.060B 0.00
InflaRx (IFRX) Germany $0.060B 0.00
Cue Biopharma (CUE) United States $0.059B 0.00
Fortress Biotech (FBIO) United States $0.059B 0.00
Adlai Nortye (ANL) Cayman Islands $0.058B 0.00
CervoMed (CRVO) United States $0.058B 0.00
Applied Therapeutics (APLT) United States $0.056B 0.00
INmune Bio (INMB) United States $0.056B 0.00
Jasper Therapeutics (JSPR) United States $0.055B 0.00
Atara Biotherapeutics (ATRA) United States $0.055B 0.00
Renovaro (RENB) United States $0.053B 0.00
ZIVO Bioscience (ZIVO) United States $0.053B 0.00
Inovio Pharmaceuticals (INO) United States $0.053B 0.00
Adverum Biotechnologies (ADVM) United States $0.053B 0.00
Annovis Bio (ANVS) United States $0.053B 0.00
Aligos Therapeutics (ALGS) United States $0.053B 0.00
VTv Therapeutics (VTVT) United States $0.053B 0.00
Precision BioSciences (DTIL) United States $0.052B 0.00
Earth Science Tech (ETST) United States $0.052B 0.00
Celularity (CELU) United States $0.051B 0.00
Quantum Biopharma (QNTM) Canada $0.049B 0.00
RenovoRx (RNXT) United States $0.048B 0.00
Werewolf Therapeutics (HOWL) United States $0.048B 0.00
Kalaris Therapeutics (KLRS) United States $0.048B 0.00
Medicus Pharma (MDCX) United States $0.045B 0.00
Exicure (XCUR) United States $0.045B 0.00
Scilex Holding (SCLX) United States $0.044B 0.00
Pluri (PLUR) Israel $0.043B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.043B 0.00
Artiva Biotherapeutics (ARTV) United States $0.042B 0.00
Grace Therapeutics (GRCE) Canada $0.042B 0.00
Mersana Therapeutics (MRSN) United States $0.042B 0.00
KALA BIO (KALA) United States $0.041B 0.00
Shattuck Labs (STTK) United States $0.039B 0.00
PepGen (PEPG) United States $0.039B 0.00
Xilio Therapeutics (XLO) United States $0.038B 0.00
Rani Therapeutics Holdings (RANI) United States $0.038B 0.00
Lantern Pharma (LTRN) United States $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.036B 0.00
Alterity Therapeutics - (ATHE) Australia $0.035B 0.00
OnKure Therapeutics (OKUR) United States $0.034B 0.00
Kezar Life Sciences (KZR) United States $0.033B 0.00
Rein Therapeutics (RNTX) United States $0.033B 0.00
Cognition Therapeutics (CGTX) United States $0.033B 0.00
Radiopharm Theranostics - (RADX) Australia $0.033B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.032B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.032B 0.00
Clene (CLNN) United States $0.032B 0.00
Femasys (FEMY) United States $0.032B 0.00
Eyenovia (HYPD) United States $0.031B 0.00
Ovid Therapeutics (OVID) United States $0.031B 0.00
CAMP4 Therapeutics (CAMP) United States $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Dyadic (DYAI) United States $0.029B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.029B 0.00
Passage Bio (PASG) United States $0.027B 0.00
ALX Oncology Holdings (ALXO) United States $0.027B 0.00
Boundless Bio (BOLD) United States $0.026B 0.00
Cadrenal Therapeutics (CVKD) United States $0.026B 0.00
Generation Bio (GBIO) United States $0.025B 0.00
FibroBiologics (FBLG) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
SAB Biotherapeutics (SABS) United States $0.024B 0.00
BioAtla (BCAB) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
CalciMedica (CALC) United States $0.023B 0.00
Longeveron (LGVN) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
Dare Bioscience (DARE) United States $0.022B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Cingulate (CING) United States $0.019B 0.00
Curis (CRIS) United States $0.019B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.019B 0.00
Hoth Therapeutics (HOTH) United States $0.019B 0.00
Rallybio (RLYB) United States $0.019B 0.00
Q32 Bio (QTTB) United States $0.018B 0.00
Beyond Air (XAIR) United States $0.018B 0.00
Gelteq (GELS) Australia $0.018B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.018B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Lexaria Bioscience (LEXX) Canada $0.016B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
HOOKIPA Pharma (HOOK) United States $0.015B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.015B 0.00
Advanced Biomed (ADVB) United States $0.015B 0.00
Synlogic (SYBX) United States $0.015B 0.00
BRIACELL THERAP (BCTX) Canada $0.014B 0.00
Leap Therapeutics (LPTX) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
Mustang Bio (MBIO) United States $0.014B 0.00
MetaVia (MTVA) United States $0.014B 0.00
Promis Neurosciences (PMN) Canada $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Imunon (IMNN) United States $0.012B 0.00
BioCardia (BCDA) United States $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Equillium (EQ) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
Artelo Biosciences (ARTL) United States $0.012B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
Cyclerion Therapeutics (CYCN) United States $0.011B 0.00
LakeShore Biopharma (LSB) China $0.011B 0.00
GeoVax Labs (GOVX) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.010B 0.00
Synaptogenix (TAOX) United States $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.010B 0.00
X4 Pharmaceuticals (XFOR) United States $0.010B 0.00
Novogen (KZIA) Australia $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Jade Biosciences (JBIO) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Evogene (EVGN) Israel $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
IN8bio (INAB) United States $0.008B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Apollomics (APLM) United States $0.006B 0.00
Mainz Biomed (MYNZ) Germany $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00